James Kahn, MD

CTSI Profile Photo

James Kahn, MD

User Profile Name
Mentoring Program Director
Professor, School of Medicine
User Profile Title
User Profile Email

Displaying 176 - 200 of 214

  1. Kahn J. Preventing hepatitis A and hepatitis B virus infections among men who have sex with men. Clin Infect Dis. 2002 Dec 01; 35(11):1382-7.
  2. Gibson DR, Brand R, Anderson K, Kahn JG, Perales D, Guydish J. Two- to sixfold decreased odds of HIV risk behavior associated with use of syringe exchange. . 2002 Oct 01; 31(2):237-42.
  3. Marseille E, Hofmann PB, Kahn JG. HIV prevention before HAART in sub-Saharan Africa. Lancet. 2002 May 25; 359(9320):1851-6.
  4. Kahn JG, Zhang X, Cross LT, Palacio H, Birkhead GS, Morin SF. Access to and use of HIV antiretroviral therapy: variation by race/ethnicity in two public insurance programs in the U.S. Public Health Rep. 2002 May-Jun; 117(3):252-62; discussion 231-2.
  5. Palacio H, Kahn JG, Richards TA, Morin SF. Effect of race and/or ethnicity in use of antiretrovirals and prophylaxis for opportunistic infection: a review of the literature. Public Health Rep. 2002 May-Jun; 117(3):233-51; discussion 231-2.
  6. Morin SF, Sengupta S, Cozen M, Richards TA, Shriver MD, Palacio H, Kahn JG. Responding to racial and ethnic disparities in use of HIV drugs: analysis of state policies. Public Health Rep. 2002 May-Jun; 117(3):263-72; discussion 231-2.
  7. Kahn JG, Marseille E. A saga in international HIV policy modeling: preventing mother-to-child HIV transmission. J Policy Anal Manage. 2002; 21(3):499-505.
  8. Heumann KS, Marx R, Lawrence SJ, Stump DL, Carroll DP, Hirozawa AM, Katz MH, Kahn JG. Cost-effectiveness of prevention referrals for high-risk HIV-negatives in San Francisco. AIDS Care. 2001 Oct; 13(5):637-42.
  9. Kahn JG, Haile B, Kates J, Chang S. Health and federal budgetary effects of increasing access to antiretroviral medications for HIV by expanding Medicaid. Am J Public Health. 2001 Sep; 91(9):1464-73.
  10. Kahn JG, Kegeles SM, Hays R, Beltzer N. Cost-effectiveness of the Mpowerment Project, a community-level intervention for young gay men. . 2001 Aug 15; 27(5):482-91.
  11. Eichner J, Kahn JG. Coordination of health coverage for Medicare enrollees: living with HIV/AIDS in California. Medicare Brief. 2001 Aug; (8):1-10.
  12. Kahn JG. Expenditures for the care of patients with HIV. N Engl J Med. 2001 Jun 21; 344(25):1948-9.
  13. Marseille E, Kahn JG, Billinghurst K, Saba J. Cost-effectiveness of the female condom in preventing HIV and STDs in commercial sex workers in rural South Africa. Soc Sci Med. 2001 Jan; 52(1):135-48.
  14. Kahn JG, Marseille E. Fighting global AIDS: the value of cost-effectiveness analysis. AIDS. 2000 Nov 10; 14(16):2609-10.
  15. Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG, Jackson JB. The cost effectiveness of a single-dose nevirapine regimen to mother and infant to reduce vertical HIV-1 transmission in sub-Saharan Africa. Ann N Y Acad Sci. 2000 Nov; 918:53-6.
  16. Pinkerton SD, Holtgrave DR, Kahn JG. Is post-exposure prophylaxis affordable? AIDS. 2000 Feb 18; 14(3):325.
  17. Kahn JG, Becker BJ, MacIsaa L, Amory JK, Neuhaus J, Olkin I, Creinin MD. The efficacy of medical abortion: a meta-analysis. Contraception. 2000 Jan; 61(1):29-40.
  18. Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG, Jackson JB. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Lancet. 1999 Sep 04; 354(9181):803-9.
  19. Johnston SC, Gress DR, Kahn JG. Which unruptured cerebral aneurysms should be treated? A cost-utility analysis. Neurology. 1999 Jun 10; 52(9):1806-15.
  20. Kahn JG, Pinkerton SD, Paltiel AD. Postexposure prophylaxis following HIV exposure. JAMA. 1999 Apr 14; 281(14):1269-70.
  21. Kahn JG, Brindis CD, Glei DA. Pregnancies averted among U.S. teenagers by the use of contraceptives. Fam Plann Perspect. 1999 Jan-Feb; 31(1):29-34.
  22. Marseille E, Kahn JG, Saba J. Cost-effectiveness of antiviral drug therapy to reduce mother-to-child HIV transmission in sub-Saharan Africa. AIDS. 1998 May 28; 12(8):939-48.
  23. Kahn JG, Gurvey J, Pollack LM, Binson D, Catania JA. How many HIV infections cross the bisexual bridge? An estimate from the United States. AIDS. 1997 Jul; 11(8):1031-7.
  24. Marx R, Franks PE, Kahn JG, Sanstad KC, Werdegar D. HIV education and prevention in California: problems and progress. HIV Education and Prevention Evaluation Team. AIDS Public Policy J. 1997; 12(1):31-45.
  25. Kahn JG, Sanstad KC. The role of cost-effectiveness analysis in assessing HIV-prevention interventions. AIDS Public Policy J. 1997; 12(1):21-30.